Mechanisms of Intrinsic Tumor Resistance to Immunotherapy

An increased understanding of the interactions between the immune system and tumors has opened the door to immunotherapy for cancer patients. Despite some success with checkpoint inhibitors including ipilimumab, pembrolizumab, and nivolumab, most cancer patients remain unresponsive to such immunothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Rieth, John, Subramanian, Subbaya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983580/
https://www.ncbi.nlm.nih.gov/pubmed/29724044
http://dx.doi.org/10.3390/ijms19051340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983580/
https://www.ncbi.nlm.nih.gov/pubmed/29724044
http://dx.doi.org/10.3390/ijms19051340

Ejemplares similares